Sterile Compounding & Compliance with USP Chapters <795>, <797> & <800>
Sterile compounding is a critical component of healthcare that ensures patients receive medications free from contamination. The United States Pharmacopeia (USP) provides comprehensive guidelines for compounding practices. Understanding and implementing the standards of USP Chapters <795>, <797>, and <800> is essential for pharmacies and healthcare facilities to maintain patient safety and regulatory compliance.
Understanding USP Chapter <795>
USP Chapter <795> provides guidelines for nonsterile compounding. Though the focus of this article is primarily on sterile compounding, understanding <795> is important as it serves as a foundation for pharmacy compounding practices.
Key aspects of USP <795> include:
- General requirements for compounding nonsterile preparations
- Facility design and engineering controls
- Quality assurance and quality control procedures
- Beyond-use dating considerations
- Storage and stability requirements
- Personnel training requirements
While <795> primarily addresses nonsterile compounding, many of its principles overlap with sterile compounding practices, particularly in areas such as documentation, personnel training, and quality assurance.
USP Chapter <797>: Sterile Compounding Standards
USP Chapter <797> sets forth the requirements for pharmaceutical compounding of sterile preparations. These standards are designed to ensure patient safety by minimizing the risk of contamination, infection, and medication errors.
Core Requirements of <797>
The chapter encompasses several critical components:
- Facility Design: Requirements for clean rooms, anterooms, and segregated compounding areas with appropriate air exchanges, pressurization, and environmental monitoring.
- Personnel Qualifications: Requirements for compounding personnel including training, competency assessment, and garbing procedures.
- Glove Fingertip Sampling: Regular testing of personnel's glove fingertips to ensure aseptic technique.
- Media-Fill Testing: Simulation of the compounding process using growth media in place of actual drug product to verify aseptic technique.
- Environmental Monitoring: Routine testing of air and surface samples to maintain acceptable microbial levels.
- Engineering Controls: Proper use of laminar airflow workbenches and biological safety cabinets.
Risk Levels in Sterile Compounding
USP <797> categorizes compounded sterile preparations into risk levels based on the conditions under which they are prepared:
| Risk Category | Description | Beyond-Use Date |
|---|---|---|
| Low Risk | Compounded with strict aseptic technique under ISO 5 conditions | 14 days (refrigerated) or hours (room temperature) depending on storage |
| Medium Risk | More complex compounding with multiple components or manipulations | 30 days (refrigerated) or 9 days (room temperature) |
| Low-Risk Medium-Risk | Preparations that require longer beyond-use dates than low-risk preparations | Variable based on stability data |
| High Risk | Compounded in environments that are not guaranteed to be sterile | 3 days (refrigerated) or only until administration |
USP Chapter <800>: Hazardous Drugs Handling
USP Chapter <800> provides standards for handling hazardous drugs to protect healthcare workers, patients, and the environment from exposure. While <800> addresses both sterile and nonsterile compounding, its requirements have significant implications for sterile compounding practices when dealing with hazardous medications.
Key Requirements of <800>
- Assessment of Hazardous Drugs: Facilities must assess which medications they handle that meet the definition of hazardous drugs.
- Categorization: Hazardous drugs are categorized based on risk level.
- Facility Design: Engineering controls, including proper ventilation and containment.
- Personal Protective Equipment (PPE):> Requirements for appropriate PPE based on the hazard level.
- Deactivation, Decontamination, and Cleaning: Procedures for safe handling and disposal.
Integrating <800> with <797>
An important aspect of compliance is understanding how USP <800> interacts with <797>. Key considerations include:
- Segregation of activities (hazardous vs. non-hazardous compounding)
- Separate engineering controls for hazardous compounding
- Enhanced personnel training on hazardous drug handling
- More stringent disposal procedures
- Different storage requirements for hazardous medications
Implementing Compliance: Strategies for Healthcare Facilities
GAP Analysis
The first step in achieving compliance is conducting a comprehensive gap analysis to compare current practices with USP requirements. This should include:
- Facility assessment
- Personnel competency evaluation
- Documentation review
- Process evaluation
Facility Design and Engineering
Ensure your compounding areas meet the physical requirements outlined in the USP chapters:
- Appropriate clean room design
- Proper HVAC systems with appropriate air changes and pressure monitoring
- Dedicated areas for different risk levels
- Appropriate containment strategies for hazardous drugs
- Primary and secondary engineering controls
Training and Competency Assessment
Develop a comprehensive training program that addresses:
- Aseptic techniques
- Garbing procedures
- Cleaning and disinfection
- Hazardous drug handling (if applicable)
- Proper use of engineering controls
- Documentation requirements
Implement regular competency assessments through:
- Media fills
- Glove fingertip testing
- Direct observation
- Written assessments
Quality Assurance and Quality Control
Robust quality systems are critical for maintaining compliance. Key components include:
- Environmental monitoring programs
- Documented policies and procedures
- Incident and error reporting
- Corrective and preventative actions
- Regular audits and self-assessments
- Stability testing and beyond-use dating documentation
Remember that compliance is not a one-time achievement but an ongoing process requiring continuous monitoring, evaluation, and improvement.
Documentation Requirements
Comprehensive documentation is essential for demonstrating compliance with USP standards. Facilities should maintain:
- Compounding records
- Environmental monitoring results
- Personnel training records
- Competency assessment results
- Equipment maintenance and certification records
- Cleaning logs
- Temperature monitoring records
- Incident reports and corrective actions
Common Challenges and Solutions
Many healthcare facilities face challenges in achieving full compliance with USP standards. Some common issues and potential solutions include:
Resource Constraints
Challenge: Limited funds for facility upgrades and equipment purchases.
Solution: Implement a phased approach to compliance, addressing high-risk issues first while developing a long-term capital improvement plan.
Personnel Training and Retention
Challenge: Maintaining compounding competency with staff turnover.
Solution: Develop comprehensive training programs with regular competency assessments and create standard operating procedures that facilitate consistent practice regardless of staff changes.
Documentation Overload
Challenge: Managing the extensive documentation required.
Solution: Implement electronic systems to streamline documentation and tracking while maintaining accessibility and security.
Integration of Standards
Challenge: Applying multiple USP chapters simultaneously.
Solution: Develop unified policies and procedures that address all relevant chapters while highlighting specific requirements unique to each standard.
Looking Ahead: Future Developments
USP standards are continuously evolving to incorporate new scientific understanding and address emerging challenges. Healthcare facilities must stay informed about:
- Updates to existing chapters
- New guidelines for emerging drug therapies
- Advancements in engineering controls and monitoring technologies
- Changes in regulatory expectations
Subscribing to USP updates and participating in professional organizations can help facilities stay current with evolving standards.
Conclusion
Compliance with USP Chapters <795>, <797>, and <800> represents a significant commitment to patient safety and quality assurance. While implementing these standards can be challenging, they provide a framework for excellence in pharmaceutical compounding.
By developing comprehensive programs that address facility design, personnel training, quality assurance, and documentation, healthcare facilities can not only achieve compliance but also establish a culture of continuous improvement in medication safety.
Ultimately, the goal of these standards is to protect patients from harm resulting from contaminated, improperly prepared, or hazardous medications. Facilities that embrace these standards as an integral part of their medication preparation processes demonstrate their commitment to the highest standards of patient care.
Sterile Compounding & Compliance With USP Chapters <795>, <797> & <800> and Reference File...
Proposed Revisions To USP Chapters 795 And 797 and Reference File Download Link
USP 795 Non Sterile Compounding Self Inspection Addendum and Reference File Download Link
USP <795> Pharmaceutical Compounding Nonsterile Preparations and Reference File Download L...
USP General Chapter <800> Hazardous Drugs Handling In Healthcare Settings and Reference Fi...